- Home
- STM vs BNTX Comparison
STM vs BNTX Comparison
Compare STM & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STM
- BNTX
- Stock Information
- Founded
- STM 1987
- BNTX 2008
- Country
- STM Netherlands
- BNTX Germany
- Employees
- STM N/A
- BNTX N/A
- Industry
- STM Semiconductors
- BNTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- STM Technology
- BNTX Health Care
- Exchange
- STM Nasdaq
- BNTX Nasdaq
- Market Cap
- STM 22.3B
- BNTX 26.4B
- IPO Year
- STM 1994
- BNTX 2019
- Fundamental
- Price
- STM $32.17
- BNTX $112.71
- Analyst Decision
- STM Buy
- BNTX Strong Buy
- Analyst Count
- STM 8
- BNTX 18
- Target Price
- STM $32.00
- BNTX $141.60
- AVG Volume (30 Days)
- STM 7.0M
- BNTX 731.1K
- Earning Date
- STM 07-24-2025
- BNTX 08-04-2025
- Dividend Yield
- STM 0.99%
- BNTX N/A
- EPS Growth
- STM N/A
- BNTX N/A
- EPS
- STM 1.18
- BNTX N/A
- Revenue
- STM $12,321,000,000.00
- BNTX $2,968,331,171.00
- Revenue This Year
- STM N/A
- BNTX N/A
- Revenue Next Year
- STM $14.19
- BNTX $10.68
- P/E Ratio
- STM $26.31
- BNTX N/A
- Revenue Growth
- STM N/A
- BNTX 0.61
- 52 Week Low
- STM $17.25
- BNTX $76.53
- 52 Week High
- STM $43.32
- BNTX $131.49
- Technical
- Relative Strength Index (RSI)
- STM 62.98
- BNTX 63.00
- Support Level
- STM $31.53
- BNTX $105.35
- Resistance Level
- STM $33.14
- BNTX $114.00
- Average True Range (ATR)
- STM 0.61
- BNTX 2.62
- MACD
- STM 0.06
- BNTX 0.53
- Stochastic Oscillator
- STM 79.26
- BNTX 89.37
About STM STMicroelectronics N.V.
A merger between Italian firm SGS Microelettronica and the nonmilitary business of Thomson Semiconducteurs in France formed STMicroelectronics in 1987. STMicroelectronics is a leader in a variety of semiconductor products, including analog chips, discrete power semiconductors, microcontrollers, and sensors. It is an especially prominent chip supplier to the industrial and automotive industries.
About BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. Covid vaccine Comirnaty is its first commercialized product.